Lifestance Health Group(LFST)
$14.37-0.19 (-1.30%)
LFST
Lifestance Health Group financials statements
$14.37
At close:-0.19 (-1.30%)
Want to see LFST full AI Analyst Report?
Lifestance Health Group (LFST) Ratios
252 Followers
Lifestance Health Group Ratios
LFST's free cash flow for Q3 2026 was $22.36M. For the 2026 fiscal year, LFST's free cash flow was decreased by $-14.65M and operating cash flow was $37.02M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.65 | 1.37 | 1.11 | 1.33 | 2.28 |
| Quick Ratio | 1.65 | 1.37 | 1.11 | 1.33 | 1.96 |
| Cash Ratio | 0.99 | 0.68 | 0.39 | 0.62 | 1.27 |
| Solvency Ratio | 0.09 | 0.02 | -0.16 | -0.22 | -0.66 |
| Operating Cash Flow Ratio | 0.58 | 0.47 | -0.08 | 0.30 | 0.08 |
| Short-Term Operating Cash Flow Coverage | 3.21 | 14.79 | -5.77 | 22.51 | 7.12 |
| Net Current Asset Value | $ -266.72M | $ -359.50M | $ -455.31M | $ -421.93M | $ -115.56M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.23 | 0.24 | 0.22 | 0.08 |
| Debt-to-Equity Ratio | 0.13 | 0.34 | 0.36 | 0.32 | 0.10 |
| Debt-to-Capital Ratio | 0.11 | 0.25 | 0.26 | 0.24 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.09 | 0.16 | 0.16 | 0.13 | 0.09 |
| Financial Leverage Ratio | 1.45 | 1.46 | 1.48 | 1.43 | 1.25 |
| Debt Service Coverage Ratio | 1.33 | 1.19 | -3.50 | -5.68 | -5.32 |
| Interest Coverage Ratio | 2.07 | -1.19 | -8.91 | -10.55 | -7.36 |
| Debt to Market Cap | 0.07 | 0.10 | 0.10 | 0.13 | 0.05 |
| Interest Debt Per Share | 0.53 | 1.35 | 1.45 | 1.40 | 0.60 |
| Net Debt to EBITDA | -0.69 | 8.29 | -4.12 | -2.58 | -0.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 32.37% | 32.17% | 28.62% | 27.57% | 30.19% |
| EBIT Margin | 1.69% | -2.48% | -17.56% | -24.76% | -44.07% |
| EBITDA Margin | 5.53% | 3.19% | -9.94% | -16.71% | -35.96% |
| Operating Profit Margin | 1.70% | -2.53% | -17.92% | -24.45% | -42.90% |
| Pretax Profit Margin | 0.87% | -4.61% | -19.57% | -27.08% | -49.90% |
| Net Profit Margin | 0.68% | -4.59% | -17.64% | -25.08% | -46.02% |
| Continuous Operations Profit Margin | 0.68% | -4.59% | -17.64% | -25.08% | -46.02% |
| Net Income Per EBT | 78.16% | 99.70% | 90.16% | 92.62% | 92.22% |
| EBT Per EBIT | 51.20% | 182.24% | 109.23% | 110.73% | 116.33% |
| Return on Assets (ROA) | 0.44% | -2.71% | -8.83% | -9.92% | -15.94% |
| Return on Equity (ROE) | 0.64% | -3.97% | -13.04% | -14.19% | -19.88% |
| Return on Capital Employed (ROCE) | 1.24% | -1.67% | -9.92% | -10.52% | -15.82% |
| Return on Invested Capital (ROIC) | 0.94% | -1.62% | -8.72% | -9.55% | -14.58% |
| Return on Tangible Assets | 1.32% | -9.06% | -31.28% | -33.81% | -72.76% |
| Earnings Yield | 0.36% | -2.06% | -6.47% | -12.28% | -9.85% |
| Efficiency Ratios | |||||
| Receivables Turnover | 14.88 | 9.48 | 8.40 | 8.47 | 6.72 |
| Payables Turnover | 157.33 | 117.17 | 32.47 | 25.54 | 32.93 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 12.24 |
| Fixed Asset Turnover | 4.58 | 3.99 | 2.94 | 2.18 | 4.38 |
| Asset Turnover | 0.65 | 0.59 | 0.50 | 0.40 | 0.35 |
| Working Capital Turnover Ratio | 11.49 | 23.50 | 26.36 | 8.31 | 8.89 |
| Cash Conversion Cycle | 22.21 | 35.41 | 32.20 | 28.82 | 73.04 |
| Days of Sales Outstanding | 24.53 | 38.52 | 43.44 | 43.10 | 54.30 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 29.82 |
| Days of Payables Outstanding | 2.32 | 3.12 | 11.24 | 14.29 | 11.08 |
| Operating Cycle | 24.53 | 38.52 | 43.44 | 43.10 | 84.12 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.38 | 0.28 | -0.05 | 0.15 | 0.03 |
| Free Cash Flow Per Share | 0.29 | 0.23 | -0.16 | -0.07 | -0.26 |
| Dividend Paid and CapEx Coverage Ratio | 4.05 | 4.97 | -0.42 | 0.67 | 0.10 |
| Capital Expenditure Coverage Ratio | 4.05 | 4.97 | -0.42 | 0.67 | 0.10 |
| Operating Cash Flow Coverage Ratio | 0.75 | 0.22 | -0.03 | 0.11 | 0.06 |
| Operating Cash Flow to Sales Ratio | 0.10 | 0.09 | -0.02 | 0.06 | 0.01 |
| Free Cash Flow Yield | 4.05% | 3.07% | -2.00% | -1.51% | -2.73% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 234.67 | -49.13 | -15.45 | -8.14 | -10.15 |
| Price-to-Sales (P/S) Ratio | 1.91 | 2.23 | 2.73 | 2.04 | 4.67 |
| Price-to-Book (P/B) Ratio | 1.79 | 1.93 | 2.01 | 1.16 | 2.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 24.70 | 32.61 | -50.12 | -66.31 | -36.65 |
| Price-to-Operating Cash Flow Ratio | 18.59 | 26.05 | -170.41 | 33.25 | 331.00 |
| Price-to-Earnings Growth (PEG) Ratio | -1.96 | 0.70 | 0.94 | 0.19 | -0.38 |
| Enterprise Value Multiple | 33.80 | 78.37 | -31.54 | -14.80 | -13.03 |
| Enterprise Value | 2.66B | 3.12B | 3.31B | 2.13B | 3.13B |
| EV to EBITDA | 33.80 | 78.37 | -31.54 | -14.80 | -13.03 |
| EV to Sales | 1.87 | 2.50 | 3.13 | 2.47 | 4.69 |
| EV to Free Cash Flow | 24.20 | 36.47 | -57.65 | -80.30 | -36.78 |
| EV to Operating Cash Flow | 18.22 | 29.13 | -196.01 | 40.26 | 332.14 |
| Tangible Book Value Per Share | 0.13 | -0.10 | -0.23 | -0.05 | 0.12 |
| Shareholders’ Equity Per Share | 3.94 | 3.81 | 3.89 | 4.27 | 4.72 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.00 | 0.10 | 0.07 | 0.08 |
| Revenue Per Share | 3.69 | 3.30 | 2.87 | 2.42 | 2.04 |
| Net Income Per Share | 0.03 | -0.15 | -0.51 | -0.61 | -0.94 |
| Tax Burden | 0.78 | 1.00 | 0.90 | 0.93 | 0.92 |
| Interest Burden | 0.51 | 1.85 | 1.11 | 1.09 | 1.13 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.27 | 0.29 | 0.39 | 0.44 | 0.65 |
| Stock-Based Compensation to Revenue | 0.05 | 0.06 | 0.09 | 0.22 | 0.39 |
| Income Quality | 15.12 | -1.87 | 0.09 | -0.24 | -0.03 |
Currency in USD
